CHANDRIKA NADIPURAM: Open Payments
NPI 1255495123 · ABERDEEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 35 payments from 7 companies in 2025. Trend: 2023 $536 · 2024 $296 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $223 |
| Neurocrine BioSciences, Inc. | 6 | $121 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, COBENFY, CAPLYTA, INVEGA SUSTENNA, SPRAVATO, AUSTEDO XR, FANAPT.
Industry payments across NJ — which companies pay providers there.
